Cargando…

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas

Molecular markers are redefining classification of lower grade gliomas and ushering in a paradigm shift in their management. Our objective was to evaluate the differences in pattern of care and outcome by comparing grade II and grade III molecularly defined 1p19q co-deleted gliomas. We evaluated 161...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeboa, Debra Nana, Yu, James B., Liao, Eric, Huse, Jason, Penas-Prado, Marta, Kann, Benjamin H., Sulman, Erik, Grosshans, David, Contessa, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329703/ https://www.ncbi.nlm.nih.gov/pubmed/30656222 http://dx.doi.org/10.1016/j.ctro.2018.12.003

Ejemplares similares

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area
por: Di Stefano, Anna Luisa, et al.
Publicado: (2014)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas
por: van Thuijl, Hinke F, et al.
Publicado: (2014)

Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma
por: Wong, Derek, et al.
Publicado: (2022)

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma
por: Lin, Wanzun, et al.
Publicado: (2021)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas
por: Kong, Ziren, et al.
Publicado: (2020)

Current therapeutic approaches to diffuse grade II and III gliomas
por: Picca, Alberto, et al.
Publicado: (2018)

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
por: Wiestler, Benedikt, et al.
Publicado: (2016)

Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion
por: Li, Yingping, et al.
Publicado: (2022)

Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas
por: Powell, Reid Trenton, et al.
Publicado: (2017)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

LGG-20. Defining subgroups in low grade gliomas by their immune and stromal microenvironment
por: Körner, Meik, et al.
Publicado: (2022)

T2 mapping of molecular subtypes of WHO grade II/III gliomas
por: Kern, Maike, et al.
Publicado: (2020)

Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence
por: Akkus, Zeynettin, et al.
Publicado: (2017)

Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients
por: Kinker, Gabriela Sarti, et al.
Publicado: (2016)

Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis
por: Upadhyay, Rituraj, et al.
Publicado: (2022)

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma()
por: Bronk, Julianna K., et al.
Publicado: (2018)

Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
por: Kha, Quang-Hien, et al.
Publicado: (2021)

Determining chromosomal arms 1p/19q co-deletion status in low graded glioma by cross correlation-periodogram pattern analysis
por: Bhattacharya, Debanjali, et al.
Publicado: (2021)

Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas
por: Wei, Xin, et al.
Publicado: (2021)

A Molecular Predictor Reassesses Classification of Human Grade II/III Gliomas
por: Rème, Thierry, et al.
Publicado: (2013)

Integrated mRNAseq and microRNAseq data analysis for grade III gliomas
por: Dai, Junqiang, et al.
Publicado: (2017)

Management and treatment recommendations for World Health Organization Grade III and IV gliomas
por: Altwairgi, Abdullah K., et al.
Publicado: (2017)

Multi-parametric arterial spin labelling and diffusion-weighted magnetic resonance imaging in differentiation of grade II and grade III gliomas
por: Razek, Ahmed Abdel Khalek Abdel, et al.
Publicado: (2020)

Radiotherapy in high grade gliomas
por: Bleehen, N.M., et al.
Publicado: (1989)

Chemotherapy for high-grade gliomas
por: Galanis, E, et al.
Publicado: (2000)

Management of Low-Grade Glioma
por: Pouratian, Nader, et al.
Publicado: (2010)

Radiosurgery for high-grade glioma
por: Binello, Emanuela, et al.
Publicado: (2012)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

Metabolomics in High Grade Gliomas
por: Yu, Nina, et al.
Publicado: (2022)

Functional characterization of the 19q12 amplicon in grade III breast cancers
por: Natrajan, Rachael, et al.
Publicado: (2012)

Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
por: Hwang, Kihwan, et al.
Publicado: (2020)

Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma
por: Lv, Lei, et al.
Publicado: (2021)

An expanded role for surgery in grade 3 1p/19q co-deleted oligodendroglioma
por: Gupta, Saksham, et al.
Publicado: (2023)

Multicellular “hotspots” harbor high-grade potential in lower-grade gliomas
por: Kirby, Alastair J, et al.
Publicado: (2021)

Diffusion Kurtosis Imaging of Gliomas Grades II and III - A Study of Perilesional Tumor Infiltration, Tumor Grades and Subtypes at Clinical Presentation
por: Delgado, Anna F., et al.
Publicado: (2017)

Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma
por: Rosenlund, Lena, et al.
Publicado: (2019)

Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1hps7k2gf1q1l75oeq3ov3e021